1. Zanatta, E, Codullo, V, Avouac, J, et al. Systemic sclerosis: recent insight in clinical management. Joint Bone Spine 2020; 87: 293–299.
Google Scholar | Crossref | Medline2. Gasparotto, M, Gatto, M, Saccon, F, et al. Pulmonary involvement in antisynthetase syndrome. Curr Opin Rheumatol 2019; 31: 603–610.
Google Scholar | Crossref | Medline3. Keane, MP, Lynch, JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55: 159–166.
Google Scholar | Crossref | Medline | ISI4. Gatto, M, Zen, M, Ghirardello, A, et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 2013; 12: 523–536.
Google Scholar | Crossref | Medline | ISI5. Quadrelli, S, Alvarez, C, Arce, S, et al. Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. Lupus 2009; 18: 1053–1060.
Google Scholar | SAGE Journals | ISI6. Flament, T, Bigot, A, Chaigne, B, et al. Pulmonary manifestations of Sjogren’s syndrome. Eur Respir Rev 2016; 25: 110–123.
Google Scholar | Crossref | Medline7. Luppi, F, Sebastiani, M, Sverzellati, M, et al. Lung complications of Sjogren syndrome. Eur Respir Rev 2020; 29: 200021.
Google Scholar | Crossref | Medline8. Palm, Ø, Garen, T, Enger, TB. Clinical pulmonary involvement in primary Sjögren’s syndrome: prevalence, quality of life and mortality—a retrospective study based on registry data. Rheumatology 2013; 52: 173–179.
Google Scholar | Crossref | Medline | ISI9. Malik, SW, Myers, JL, DeRemee, RA, et al. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 1996; 154: 1851–1856.
Google Scholar | Crossref | Medline | ISI10. Lateef, O, Shakoor, N, Balk, RA. Methotrexate pulmonary toxicity. Expert Opin Drug Saf 2005; 4: 723–730.
Google Scholar | Crossref | Medline11. Orens, JB, Martinez, FJ, Lynch, JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994; 20: 159–193.
Google Scholar | Crossref | Medline | ISI12. Haupt, HM, Moore, GW, Hutchins, GM. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981; 71: 791–798.
Google Scholar | Crossref | Medline | ISI13. Fanouriakis, A, Kostopoulou, M, Alunno, A, et al. Update 19 of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019; 78: 736–745.
Google Scholar | Crossref | Medline14. Mittoo, S, Fell, C. Pulmonary manifestations of systemic lupus erythematosus. Semin Respir Crit Care Med 2014; 35: 249–254.
Google Scholar | Crossref | Medline | ISI15. Palavutitotai, N, Buppajarntham, T, Katchamart, W. Etiologies and outcomes of pleural effusions in patients with systemic lupus erythematosus. J Clin Rheumatol 2014; 20: 418–421.
Google Scholar | Crossref | Medline16. Hellman, DB, Kirsch, CM, Whiting-O’Keefe, Q, et al. Dyspnea in ambulatory patients with SLE: prevalence, severity, and correlation with incremental exercise testing. J Rheumatol 1995; 22: 455–461.
Google Scholar | Medline | ISI17. Bouros, D, Panagou, P, Papandreou, L, et al. Massive bilateral pleural effusion as the only first presentation of systemic lupus erythematosus. Respiration 1992; 59: 173–175.
Google Scholar | Crossref | Medline18. Sharma, S, Smith, R, Al-Hameed, F. Fibrothorax and severe lung restriction secondary to lupus pleuritis and its successful treatment by pleurectomy. Can Respir J 2002; 9: 335–337.
Google Scholar | Crossref | Medline19. Rojas-Serrano, J, Pedroza, J, Regalado, J, et al. High prevalence of infections in patients with systemic lupus erythematosus and pulmonary hemorrhage. Lupus 2008; 17: 295–299.
Google Scholar | SAGE Journals | ISI20. Man, BL, Mok, CC. Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 2005; 14: 822–826.
Google Scholar | SAGE Journals | ISI21. ter Borg, EJ, Horst, G, Limburg, PC, et al. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 1990; 17: 1642–1648.
Google Scholar | Medline | ISI22. Good, JT, King, TE, Antony, VB, et al. Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983; 84: 714–718.
Google Scholar | Crossref | Medline | ISI23. Porcel, JM, Ordi-Ros, J, Esquerda, A, et al. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis. Lupus 2007; 16: 25–27.
Google Scholar | SAGE Journals | ISI24. Pandya, MR, Agus, B, Grady, RF. In vivo LE phenomenon in pleural fluid. Arthritis Rheum 1976; 19: 962–963.
Google Scholar | Crossref | Medline25. Iaccarino, L, Rampudda, M, Canova, M, et al. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev 2007; 6: 190–195.
Google Scholar | Crossref | Medline26. Depascale, R, Gatto, M, Zen, M, et al. Belimumab: a step forward in the treatment of systemic lupus erythematosus. Expert Opin Biol Ther 2021; 21: 563–573.
Google Scholar | Crossref | Medline27. Iaccarino, L, Andreoli, L, Bocci, EB, et al. Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study. J Autoimmun 2018; 86: 1–8.
Google Scholar | Crossref | Medline28. Trentin, F, Gatto, M, Zen, M, et al. Effectiveness, tolerability, and safety of belimumab in patients with refractory SLE: a review of observational clinical-practice-based studies. Clin Rev Allergy Immunol 2018; 54: 331–343.
Google Scholar | Crossref | Medline29. Doria, A, Stohl, W, Schwarting, A, et al. Efficacy and safety of subcutaneous belimumab in anti-double-stranded DNA-positive, hypocomplementemic patients with systemic lupus erythematosus. Arthritis Rheum 2018; 70: 1256–1264.
Google Scholar | Crossref30. Gatto, M, Saccon, F, Zen, M, et al. Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a real-life setting. Arthritis Rheum 2020; 72: 1314–1324.
Google Scholar | Crossref | Medline31. Carrión-Barberà, I, Salman-Monte, TC, Castell, S, et al. Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab. Eur J Rheumatol 2019; 6: 150–152.
Google Scholar | Crossref | Medline32. Matthay, RA, Schwarz, MI, Petty, TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine 1975; 54: 397–409.
Google Scholar | Crossref | Medline | ISI33. Tselios, K, Urowitz, MB. Cardiovascular and pulmonary manifestations of systemic lupus erythematosus. Curr Rheumatol Rev 2017; 13: 206–218.
Google Scholar | Crossref | Medline34. Ahuja, J, Arora, D, Kanne, JP, et al. Imaging of pulmonary manifestations of connective tissue diseases. Radiol Clin North Am 2016; 54: 1015–1031.
Google Scholar | Crossref | Medline35. Swigris, JJ, Fischer, A, Gillis, J, et al. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest 2008; 133: 271–280.
Google Scholar | Crossref | Medline | ISI36. Rodríguez-Iturbe, B, García, R, Rubio, L, et al. Immunohistologic findings in the lung in systemic lupus erythematosus. Arch Pathol Lab Med 1977; 101: 342–344.
Google Scholar | Medline | ISI37. Kichloo, A, Aljadah, M, Albosta, M, et al. COVID-19 and acute lupus pneumonitis: diagnostic and treatment dilemma. J Investig Med High Impact Case Rep 2020; 8: 2324709620933438.
Google Scholar | SAGE Journals | ISI38. Zen, M, Fuzzi, E, Astorri, D, et al. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients. J Autoimmun 2020; 112: 102502.
Google Scholar | Crossref | Medline39. Badsha, H, Teh, CL, Kong, KO, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2004; 33: 414–421.
Google Scholar | Crossref | Medline | ISI40. Andrade, C, Mendonca, T, Farinha, F, et al. Alveolar hemorrhage in systemic lupus erythematosus: a cohort review. Lupus 2016; 25: 75–80.
Google Scholar | SAGE Journals | ISI41. Zamora, MR, Warner, ML, Tuder, R, et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine 1997; 76: 192–202.
Google Scholar | Crossref | Medline | ISI42. Lara, AR, Schwarz, MI. Diffuse alveolar hemorrhage. Chest 2010; 137: 1164–1171.
Google Scholar | Crossref | Medline | ISI43. Hughson, MD, He, Z, Henegar, J, et al. Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus. Arch Pathol Lab Med 2001; 125: 475–483.
Google Scholar | Crossref | Medline | ISI44. Bajema, IM, Wilhelmus, S, Alpers, CE. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 2018; 93: 789–796.
Google Scholar | Crossref | Medline45. Sun, Y, Zhou, C, Zhao, J, et al. Systemic lupus erythematosus-associated diffuse alveolar hemorrhage: a single-center, matched case-control study in China. Lupus 2020; 29: 795–803.
Google Scholar | SAGE Journals | ISI46. Cartin-Ceba, R, Peikert, T, Ashrani, A, et al. Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage. Arthritis Care Res 2014; 66: 301–310.
Google Scholar | Crossref | Medline47. Myers, JL, Katzenstein, AA. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986; 85: 552–556.
Google Scholar | Crossref | Medline | ISI48. Al-Adhoubi, NK, Bystrom, J. Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies. Lupus 2020; 29: 355–363.
Google Scholar | SAGE Journals | ISI49. Zhuang, H, Han, S, Lee, PY, et al. Pathogenesis of diffuse alveolar hemorrhage in murine lupus. Arthritis Rheum